share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144:擬議出售證券
美股sec公告 ·  06/26 22:28
牛牛AI助理已提取核心訊息
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 06/26/2024, with an aggregate market value of $1,075,521.60. The shares were acquired on 02/17/2024 as part of a restricted stock vesting and were compensation from the issuer. This planned sale follows a recent transaction history where Bozic sold a total of 4,560 shares over the past three months, generating total gross proceeds of $2,105,716.80.
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 06/26/2024, with an aggregate market value of $1,075,521.60. The shares were acquired on 02/17/2024 as part of a restricted stock vesting and were compensation from the issuer. This planned sale follows a recent transaction history where Bozic sold a total of 4,560 shares over the past three months, generating total gross proceeds of $2,105,716.80.
Vertex製藥公司高管Carmen Bozic計劃於2024年6月26日出售2,280股普通股,合計市場價值爲1,075,521.60美元。這些股票是在2024年2月17日作爲限制性股票的授予獲得的,並且是來自發行人的補償。此次計劃的銷售是在Bozic過去三個月內出售了總共4,560股股票、產生了總毛收益2,105,716.80美元之後進行的。
Vertex製藥公司高管Carmen Bozic計劃於2024年6月26日出售2,280股普通股,合計市場價值爲1,075,521.60美元。這些股票是在2024年2月17日作爲限制性股票的授予獲得的,並且是來自發行人的補償。此次計劃的銷售是在Bozic過去三個月內出售了總共4,560股股票、產生了總毛收益2,105,716.80美元之後進行的。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。